These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1405318)

  • 1. Renal effect of anti-hypertensive drugs depends on sodium diet in the excision remnant kidney model.
    Terzi F; Beaufils H; Laouari D; Burtin M; Kleinknecht C
    Kidney Int; 1992 Aug; 42(2):354-63. PubMed ID: 1405318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
    Krivosíková Z; Sebeková K; Spustová V; Lajdová I; Dzúrik R
    Physiol Res; 1999; 48(6):429-35. PubMed ID: 10783907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
    Okada H; Suzuki H; Kanno Y; Ikenaga H; Saruta T
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of the timing of initiating antihypertensive therapy in hypertensive rats with renal failure.
    Kanno Y; Okada H; Takenaka T; Saruta T; Suzuki H
    Clin Exp Hypertens; 2000 Jul; 22(5):521-9. PubMed ID: 10937842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II blockade on renal injury in mineralocorticoid-salt hypertension.
    Sorooshian M; Olson JL; Meyer TW
    Hypertension; 2000 Oct; 36(4):569-74. PubMed ID: 11040237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S
    Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of hypertension with captopril affords better renal protection as compared with irbesartan in salt-loaded uremic rats.
    Weissgarten J; Berman S; Efrati S; Rapoport M; Modai D; Cohn M; Aladjem M; Galperin E; Averbukh Z
    Nephron Physiol; 2005; 101(1):p14-20. PubMed ID: 15925907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
    Mackie FE; Meyer TW; Campbell DJ
    Kidney Int; 2002 Feb; 61(2):555-63. PubMed ID: 11849396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal autoregulation and vulnerability to hypertensive injury in remnant kidney.
    Bidani AK; Schwartz MM; Lewis EJ
    Am J Physiol; 1987 Jun; 252(6 Pt 2):F1003-10. PubMed ID: 3591950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model.
    Nangaku M; Miyata T; Sada T; Mizuno M; Inagi R; Ueda Y; Ishikawa N; Yuzawa H; Koike H; van Ypersele de Strihou C; Kurokawa K
    J Am Soc Nephrol; 2003 May; 14(5):1212-22. PubMed ID: 12707391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of antihypertensive therapy on the renal function in spontaneously hypertensive rats (SHR) with renal ablation].
    Kanazawa M; Abe K; Yasujima M; Yoshida K; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):33-44. PubMed ID: 2348572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of enalapril and valsartan in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet.
    Lassila M; Finckenberg P; Pere AK; Krogerus L; Ahonen J; Vapaatalo H; Nurminen ML
    Br J Pharmacol; 2000 Jul; 130(6):1339-47. PubMed ID: 10903974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.
    Mizobuchi M; Morrissey J; Finch JL; Martin DR; Liapis H; Akizawa T; Slatopolsky E
    J Am Soc Nephrol; 2007 Jun; 18(6):1796-806. PubMed ID: 17513326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of omapatrilat on blood pressure and renal injury in L-NAME and L-NAME plus DOCA-treated rats.
    Rodriguez-Gomez I; Wangensteen R; Atucha NM; O'Valle F; Del Moral RG; Garcia-Estañ J; Vargas F; Osuna A
    Am J Hypertens; 2003 Jan; 16(1):33-8. PubMed ID: 12517680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of renal damage by angiotensin II blockade, accompanied by increased renal hepatocyte growth factor in experimental hypertensive rats.
    Matsumoto K; Morishita R; Moriguchi A; Tomita N; Yo Y; Nishii T; Nakamura T; Higaki J; Ogihara T
    Hypertension; 1999 Aug; 34(2):279-84. PubMed ID: 10454454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
    Hayashi M; Uchida S; Kawamura T; Kuwahara M; Nangaku M; Iino Y;
    Clin Exp Nephrol; 2015 Oct; 19(5):925-32. PubMed ID: 25680887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combining an ACE inhibitor and a VDR activator on glomerulosclerosis, proteinuria, and renal oxidative stress in uremic rats.
    Finch JL; Suarez EB; Husain K; Ferder L; Cardema MC; Glenn DJ; Gardner DG; Liapis H; Slatopolsky E
    Am J Physiol Renal Physiol; 2012 Jan; 302(1):F141-9. PubMed ID: 21957179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats.
    Hamming I; Navis G; Kocks MJ; van Goor H
    J Pathol; 2006 May; 209(1):129-39. PubMed ID: 16532430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term enalapril and verapamil in rats with reduced renal mass.
    Brunner FP; Thiel G; Hermle M; Bock HA; Mihatsch MJ
    Kidney Int; 1989 Dec; 36(6):969-77. PubMed ID: 2557483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.